These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. RACK1: a novel substrate for the Src protein-tyrosine kinase. Chang BY; Harte RA; Cartwright CA Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005 [TBL] [Abstract][Full Text] [Related]
6. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739 [TBL] [Abstract][Full Text] [Related]
7. A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways. Mamidipudi V; Cartwright CA Oncogene; 2009 Dec; 28(50):4421-33. PubMed ID: 19767770 [TBL] [Abstract][Full Text] [Related]
8. A target for Src in mitosis. Fumagalli S; Totty NF; Hsuan JJ; Courtneidge SA Nature; 1994 Apr; 368(6474):871-4. PubMed ID: 7512695 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration. Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158 [TBL] [Abstract][Full Text] [Related]
10. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Kraus S; Gioeli D; Vomastek T; Gordon V; Weber MJ Cancer Res; 2006 Nov; 66(22):11047-54. PubMed ID: 17108144 [TBL] [Abstract][Full Text] [Related]
11. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Staley CA; Parikh NU; Gallick GE Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668 [TBL] [Abstract][Full Text] [Related]
12. RACK1 regulates Src activity and modulates paxillin dynamics during cell migration. Doan AT; Huttenlocher A Exp Cell Res; 2007 Jul; 313(12):2667-79. PubMed ID: 17574549 [TBL] [Abstract][Full Text] [Related]
13. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207 [TBL] [Abstract][Full Text] [Related]
14. The role of insulin receptor substrate-1 in transformation by v-src. Sun H; Baserga R J Cell Physiol; 2008 Jun; 215(3):725-32. PubMed ID: 18064649 [TBL] [Abstract][Full Text] [Related]
15. P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras. Huang JW; Chen CL; Chuang NN Biochem Biophys Res Commun; 2005 Apr; 329(3):855-62. PubMed ID: 15752734 [TBL] [Abstract][Full Text] [Related]
17. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins. Planas-Silva MD; Hamilton KN Cancer Chemother Pharmacol; 2007 Sep; 60(4):535-43. PubMed ID: 17186241 [TBL] [Abstract][Full Text] [Related]
18. Effects of RACK1 on cell migration and IGF-I signalling in cardiomyoctes are not dependent on an association with the IGF-IR. O'Donovan HC; Kiely PA; O'Connor R Cell Signal; 2007 Dec; 19(12):2588-95. PubMed ID: 17900863 [TBL] [Abstract][Full Text] [Related]